Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  4,859 results for ""Sodium-Glucose Transporter 2 Inhibitors""

Your Filters

Subject : biomarkers Subject : diabetes mellitus, type 2 Subject : glucose intolerance Subject : insulin-secreting cells Subject : renal insufficiency, chronic
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Changes in Cardiovascular and Renal Biomarkers Associated with SGLT2 Inhibitors Treatment in Patients with Type 2 Diabetes Mellitus.

Subjects: *SODIUM-glucose cotransporters; *TYPE 2 diabetes; *SODIUM-glucose cotransporter 2 inhibitors

  • Source: Pharmaceutics. Nov2023, Vol. 15 Issue 11, p2526. 19p.

Record details

Read More Add to Saved list
×
Academic Journal

USE OF SODIUM GLUCOSE COTRANSPORTER TYPE 2 INHIBITORS IN THE CONTEXT OF TYPE 2 DIABETES MELLITUS.

Subjects: *SODIUM-glucose cotransporters; *TYPE 2 diabetes; *SODIUM-glucose cotransporter 2 inhibitorsWORLD Health Organization

  • Source: Acta Medica Transilvanica. Sep2023, Vol. 28 Issue 3, p33-35. 3p.

Record details

Read More Add to Saved list
×
Academic Journal

Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study.

  • Authors : Matsuba I; The Study Group of the Diabetes Committee, Kanagawa Physicians Association, Yokohama, Japan.; Kawata T

Subjects: Biomarkers/Biomarkers/Biomarkers/*analysis ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*complications ; Diabetic Nephropathies/Diabetic Nephropathies/Diabetic Nephropathies/*drug therapy

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2020 Sep; Vol. 11 (5), pp. 1248-1257. Date of Electronic Publication: 2020 Apr 25.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Protective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease and type 2 diabetes.

  • Authors : Miyoshi H; Division of Diabetes and Obesity, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Subjects: Glomerular Filtration Rate*; Biomarkers/Biomarkers/Biomarkers/*analysis ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2019 Nov; Vol. 10 (6), pp. 1510-1517. Date of Electronic Publication: 2019 May 17.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Factors affecting the sodium-glucose cotransporter 2 inhibitors-related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease Database.

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Glomerular Filtration Rate*/Glomerular Filtration Rate*/Glomerular Filtration Rate*/drug effects

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jul; Vol. 26 (7), pp. 2905-2914. Date of Electronic Publication: 2024 May 08.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The effect of sodium-glucose cotransporter-2 inhibitors on inflammatory biomarkers: A meta-analysis of randomized controlled trials.

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/pharmacology ; Randomized Controlled Trials as Topic*

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jul; Vol. 26 (7), pp. 2706-2721. Date of Electronic Publication: 2024 Apr 11.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure.

  • Authors : Wang DD; Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA, USA.; Naumova AV

Subjects: Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/therapeutic use ; Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/adverse effects ; Glucosides*/Glucosides*/Glucosides*/therapeutic use

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Jun 07; Vol. 23 (1), pp. 197. Date of Electronic Publication: 2024 Jun 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease.

  • Authors : Yen FS; Dr. Yen's Clinic, Taoyuan, Taiwan (F.-S.Y.).; Hwu CM

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Annals of internal medicine [Ann Intern Med] 2024 Jun; Vol. 177 (6), pp. 693-700. Date of Electronic Publication: 2024 Apr 30.Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project).

  • Authors : Nielsen SF; University Clinic in Nephrology and Hypertension, Gødstrup Hospital and Aarhus University, Herning, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Subjects: Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/drug therapy ; Cross-Over Studies* ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: JMIR research protocols [JMIR Res Protoc] 2024 May 29; Vol. 13, pp. e56067. Date of Electronic Publication: 2024 May 29.Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101599504 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Sotagliflozin and Kidney Outcomes, Kidney Function, and Albuminuria in Type 2 Diabetes and CKD: A Secondary Analysis of the SCORED Trial.

  • Authors : Sridhar VS; Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Bhatt DL

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/mortality

  • Source: Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2024 May 01; Vol. 19 (5), pp. 557-564. Date of Electronic Publication: 2024 Jan 26.Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101271570 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  4,859 results for ""Sodium-Glucose Transporter 2 Inhibitors""